Request for Offers No. 23/2018 – ARG/STRATEGMED
The order carried out as a part of the projects titled:
STRATEGMED: DEVELOPMENT OF NEW CANCER THERAPIES BASED ON SELECTIVE ANTITUMOR IMMUNOMODULATORS (STRATEGMED2/265503/3/NCBR/15) and
ARG: PRE-CLINICAL AND CLINICAL DEVELOPMENT OF AN ARGINASE INHIBITOR FOR CANCER IMMUNOTHERAPY (POIR.01.01.01-00-415/17)
co-financed by the National and European Union Funds and because of the competitiveness principle.
We hereby look for Contractor ready to perform the service:
Delivery of the chemical reagent – the building block for the synthesis of arginase inhibitors, for the period of 6 months from the date of signing the contract.
Request for offers 23_2018
Appendices to request 23_2018
Appendix 4_ CDA